TipHub

19.46

+1.57 +8.78%

30 Jul 2026

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-06-25

Venmax Drugs & Pharmaceuticals Ltd. (531015)

Volume: 4,621Avg Vol 1W: 6,338Avg Vol 1M: 6,35652W Range:15.5636.96
Key Ratios
Checked 5h ago
Market Cap₹22 Cr
Current Price₹19.46
Previous Close₹17.89
High / Low (52w)₹36.96 / ₹15.56
Volume4,621
Avg Vol (1W)6,338
Avg Vol (1M)6,356
Stock P/E89.76
Book Value₹12.18
Dividend Yield0%
ROE175.83%
ROA123.46%
Revenue (TTM)
Revenue Growth
Profit Margin249.38%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹0.21
P/B1.55
Debt / Equity0.11
50 DMA₹19.81
200 DMA₹24.5
Day change+8.78%
SurveillanceGSM · GSM 0
Price Chart
19.46 30.15% · 1Y
351653K
2025-07-30
2026-07-30

20-day avg volume: 7K shares

Pros
  • Healthy return on equity of 175.8%.
  • Company is almost debt-free.
  • Revenue grew 837% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 90.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹4 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹2 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-0.46-0.45-0.52-0.313.520.430.12-0.02
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹5 Cr
Total Liabilities₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Equity₹-2 Cr₹-2 Cr₹-3 Cr₹-3 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹4 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹-2 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹-2 Cr₹0 Cr₹0 Cr₹5 Cr
Free Cash Flow₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹-2 Cr
Shareholding
Promoter 10.46% Institutions 0% Public 89.54%
Efficiency & Working Capital
ROCE1.9%
Interest Coverage0
Dividend Payout
Debtor Days
Inventory Days
Payable Days
Cash Conversion Cycle
Working Capital Days
Shareholding Details

As of 2026-06-30

Promoter10.5%
FII0%
DII0%
Institutions0%
Public89.5%
Promoter Pledge0%
No. of Shareholders6,865
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters23.1%23.1%23.1%23.1%23.1%23.1%23.1%23.1%23.1%15.1%13.8%10.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.1%0.1%0.1%0.1%0.1%0.1%0.1%0%0%0%0%0%
Public76.7%76.7%76.7%76.7%76.7%76.7%76.7%76.9%76.9%84.9%86.2%89.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders6,2506,2526,2516,2526,2916,6576,7566,7296,7646,8156,8026,865
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Pushpa BhajuPublic Shareholding13%15,00,000
Jugal Kishore BhagatPublic Shareholding11.2%13,00,000
Venkat Narender NukaShareholding of Promoter and Promoter Group8%9,26,775
Manish GroverPublic Shareholding4.8%5,50,000
Percy Homi ItaliaPublic Shareholding4%4,66,161
Wca Services Private LimitedPublic Shareholding3.5%4,03,333
Mega Flex Plastics LimitedPublic Shareholding2.6%3,00,000
Dr Tadla Tirumal RaoPublic Shareholding2.3%2,69,900
Shammi KhannaPublic Shareholding2.2%2,50,000
Dwarka Prasad GattaniPublic Shareholding1.7%2,00,000
J MuralidharanPublic Shareholding1.7%2,00,000
White Saffron Grains LlpPublic Shareholding1.7%2,00,000
Sampati Devi JainPublic Shareholding1.7%2,00,000
Vincent Alex D'melloPublic Shareholding1.3%1,50,000
Channel Plastics Private LimitedPublic Shareholding1.3%1,45,000
Sankalp Sunil WakkarPublic Shareholding1.1%1,25,000
N Achuta BaiShareholding of Promoter and Promoter Group0.9%1,04,250
Banda UshaShareholding of Promoter and Promoter Group0.1%12,250
Banda ShamraoShareholding of Promoter and Promoter Group0.1%6,250
N Jyothi KiranShareholding of Promoter and Promoter Group0%5,000
G PadmajaShareholding of Promoter and Promoter Group0%5,000
K ChakradharShareholding of Promoter and Promoter Group0%5,000
Mohan Naidu ChoppaShareholding of Promoter and Promoter Group0%5,000
Naresh VShareholding of Promoter and Promoter Group0%2,500
R PadmavatammaShareholding of Promoter and Promoter Group0%2,500
Board of Directors
NameDesignationYear
Sadhanala Venkata RaoWhole-time Director2025
Swapneswar MishraNon-Exec & Non-Independent Dir2025
D. Rakesh ReddyNon-Exec & Non-Independent Dir2025
Mr Reddeppa GundluruIndependent Non Exe. Director2025
Dakshita JainIndependent Non Exe. Director2025
Priyanka AgarwalCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹102255
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2023000000
2023000000
2023000000
Company Information
Incorporated1988
AuditorPPKG & Co
Investor Email[email protected]
🌐 www.venmaxdrugs.com

📍 Sy No 115 Brig Sayeed Road, Hanumanji Colony Old Bowenpall, Secunderabad, Telangana, 500009

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search